Bridgewater Associates’s Transmedics TMDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-30,085
Closed -$3.38M 1178
2025
Q3
$3.38M Buy
+30,085
New +$3.52M 0.01% 586
2025
Q1
Sell
-3,463
Closed -$216K 795
2024
Q4
$216K Sell
3,463
-1,409
-29% -$131K ﹤0.01% 671
2024
Q3
$765K Sell
4,872
-17,324
-78% -$2.67M ﹤0.01% 634
2024
Q2
$3.34M Buy
22,196
+15,907
+253% +$1.91M 0.02% 436
2024
Q1
$465K Sell
6,289
-1,137
-15% -$93.7K ﹤0.01% 631
2023
Q4
$586K Sell
7,426
-2,915
-28% -$176K ﹤0.01% 691
2023
Q3
$566K Buy
10,341
+405
+4% +$29.2K ﹤0.01% 677
2023
Q2
$834K Sell
9,936
-565
-5% -$43.3K 0.01% 601
2023
Q1
$795K Sell
10,501
-25,316
-71% -$1.75M ﹤0.01% 584
2022
Q4
$2.21M Sell
35,817
-11,072
-24% -$589K 0.01% 514
2022
Q3
$1.96M Buy
46,889
+26,063
+125% +$1.13M 0.01% 568
2022
Q2
$655K Buy
+20,826
New +$555K ﹤0.01% 864
2022
Q1
Sell
-26,125
Closed -$501K 982
2021
Q4
$501K Sell
26,125
-3,201
-11% -$80.2K ﹤0.01% 647
2021
Q3
$970K Buy
29,326
+121
+0.4% +$3.7K 0.01% 521
2021
Q2
$969K Buy
+29,205
New +$809K 0.01% 595

Other funds holding TMDX

Bridgewater Associates's TMDX Position: Q4 2025 in Review

Bridgewater Associates sold out of Transmedics (TMDX) in Q4 2025, closing a stake of 30,085 shares — an estimated $3.38M sold.

Bridgewater Associates first reported a position in TMDX in Q2 2021 and held it in 15 quarters. The position peaked at $3.38M in Q3 2025. 428 funds tracked by Wall St. Rank hold TMDX as of Q4 2025.

  • Bridgewater Associates reported no remaining Transmedics position as of Q4 2025 after selling out during the quarter.
  • Bridgewater Associates sold 30,085 Transmedics shares in Q4 2025, an estimated $3.38M.
  • Bridgewater Associates first reported a position in Transmedics in Q2 2021 and held it in 15 quarters.
  • Bridgewater Associates's Transmedics position peaked at $3.38M in Q3 2025.
  • 428 funds tracked by Wall St. Rank held Transmedics as of Q4 2025.

Based on Bridgewater Associates's 13F filing for Q4 2025, filed 13 Feb 2026.